chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Reaction at the injection site about 2 inches wide, a circle; Severe itching; Pain; Sore; Raised; Hard; Warm to touch; When she moves her arm it hurts; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE REACTION (Reaction at the injection site about 2 inches wide, a circle), PRURITUS (Severe itching), PAIN (Pain), VACCINATION SITE PAIN (Sore) and VACCINATION SITE SWELLING (Raised) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced VACCINATION SITE REACTION (Reaction at the injection site about 2 inches wide, a circle), PRURITUS (Severe itching), PAIN (Pain), VACCINATION SITE PAIN (Sore), VACCINATION SITE SWELLING (Raised), VACCINATION SITE INDURATION (Hard), VACCINATION SITE WARMTH (Warm to touch) and PAIN IN EXTREMITY (When she moves her arm it hurts). At the time of the report, VACCINATION SITE REACTION (Reaction at the injection site about 2 inches wide, a circle), PRURITUS (Severe itching), PAIN (Pain), VACCINATION SITE PAIN (Sore), VACCINATION SITE SWELLING (Raised), VACCINATION SITE INDURATION (Hard), VACCINATION SITE WARMTH (Warm to touch) and PAIN IN EXTREMITY (When she moves her arm it hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
MMR was given on 12/12/19 prior to patient being aware she was pregnant.  LMP 12/1/19.  EDC 9/6/20.
Information has been received on 22-FEB-2019 regarding a case in litigation from a lawyer concerning a female patient of unknown age. There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. In or around 21-MAR-2017, the patient was inoculated with the ZOSTAVAX (lot number, expiration, dose and route unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster.) One week after receiving the ZOSTAVAX, the patient suffered Zoster Ocular Disease, Nuclear Sclerosis OU, Acute allergic conjunctivitis OU, Punctuate Keratitis OS, Herpes Zoster Keratouveitis OS and Dry Eye Syndrome. As a direct and proximate result of ZOSTAVAX the patient's symptoms have resulted in physical limitations not present prior to using ZOSTAVAX. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of the patient's condition. As a result of ZOSTAVAX, the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of ZOSTAVAX, the patient suffered serious, progressive, permanent and incurable injuries, as well as conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The patient has suffered and incurred damages, including medical expenses, loss of accumulations and other economic and non-economic damages. As a direct and proximate consequence of ZOSTAVAX, the patient sustained serious personal injuries and related losses including but not limited to the patient required and will continue to require healthcare and services; the patient incurred and will continue to incur medical and related expenses; and the patient suffered and will continue to suffer mental anguish, physical pain and suffering, diminished capacity for the enjoyment of life, a diminished quality of life and other losses and damages. The outcome of the events is not recovered. The causality of the events is related. Zoster Ocular Disease, Nuclear Sclerosis OU, Acute allergic conjunctivitis OU, Punctuate Keratitis OS, Herpes Zoster Keratouveitis OS and Dry Eye Syndrome were considered to be disabling. Upon internal review, Zoster Ocular Disease, Punctuate Keratitis OS, and Herpes Zoster Keratouveitis OS were considered to be medically significant. Additional information has been requested.
Patient reported a large, red, warm, tender/painful area approximately 2 inches in diameter at the site of vaccine administration with two raised, red streaks that radiated into the right axilla.  She also noted a hard nodule in the right axilla.  Cefazolin 1 gram every 8 hours was prescribed for empiric coverage of presumed injection site cellulitis.
Mid April, I suffered telogen effeluvium. After I received my booster shot on September 30th, the same thing happened. I am a 40 year old female who previously had beautiful hair and I am now almost bald.
pt devel infantile spasms (sz) well controlled w/a course of ACTH still some motor delay;
Took Vivotif which was left unrefrigerated for a week; Spontaneous report received on 09DEC2019.  A pharmacist reported that a female consumer who "took Vivotif which was left unrefrigerated for a week" (PT: Product storage error), while being on oral Vivotif for typhoid fever prophylaxis. The consumer left Vivotif unrefrigerated for a week and took the unrefrigerated doses. The reporter did not know how many unrefrigerated doses the consumer took. Action taken with Vivotif with respect to the reported event was not applicable. Outcome of the reported event was unknown.  Company Comment: A consumer left Vivotif unrefrigerated for a week and took unrefrigerated Vivotif doses (Incorrect product storage). Considering the nature of the event, the causality of the event is assessed as not related.; Sender's Comments: A consumer left Vivotif unrefrigerated for a week and took unrefrigerated Vivotif doses (Incorrect product storage). Considering the nature of the event, the causality of the event is assessed as not related.
Pt seen 8/2/16 with redness/swelling at inj. site given cephalexin and told to go to ER if worse. Admitted through ER hospitalized 8/3-8/5/2016. Dx cellulitis and allergic reaction.
8 days post injection, I developed a large hive in the injection area. It was very itchy, red, tender.
after 24 hours small redness and itchy; Sore arm up to 48 hours; after 24 hours small redness and itchy; This is a spontaneous report from a contactable consumer or other non health care professional (Patient). A 32-years-old non pregnant female patient received bnt162b2 (BNT162B2, PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 16Feb2021 12:00 as unknown single dose for covid-19 immunization. (Vaccination facility: Pharmacy or Drug Store). The patient medical history was not reported. Concomitant medication included sertraline hydrochloride (ZOLOFT) taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccine within four weeks. Patient was not diagnosed with covid prior to vaccination. Had no allergies. On 17Feb2021 19:00 patient experienced Sore arm up to 48 hours and after 24 hours small redness and itchy. Patient was not tested for covid post vaccination. Patient did not receive any treatment for the events. The outcome for the events was reported as resolving at the time of this report.  Follow-up (12May2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
My son developed a rash on his bottom, upper legs and forearms. His eyes became puffy. He took OTC allergy medicine and it cleared the symptoms quickly.
Bruising and pain in upper left arm since yesterday. PA advised rest, heat pad and NSAID OTC for the new few days.
Vaccine given on the Left Deltoid. Vaccine was given 3 hours after beyond used time.
Missed a full cycle menstrual period. I have never missed a cycle previously is over twenty years. The next month (May 2021) extreme pain, fatigue, cramping and bleeding with my regular cycle. Intermittent spotting.
Swollen and sore lymph nodes in left arm pit for about a week.  Red itchy rash on left arm at injection site for about 3 days.   Both of these symptoms started about a week after the vaccine.
Muscle soreness; Itching on the arms; Redness; Rashes on the arm down the elbow; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching on the arms), ERYTHEMA (Redness), RASH (Rashes on the arm down the elbow) and MYALGIA (Muscle soreness) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced PRURITUS (Itching on the arms). On an unknown date, the patient experienced ERYTHEMA (Redness), RASH (Rashes on the arm down the elbow) and MYALGIA (Muscle soreness). At the time of the report, PRURITUS (Itching on the arms), ERYTHEMA (Redness) and RASH (Rashes on the arm down the elbow) had resolved and MYALGIA (Muscle soreness) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use included thyroid medication.  Treatment: Benadryl and Triple Antibiotic Ointment.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow up information was received on 11 May 2021 wherein treatment, event outcome and event were added.
Received vaccination 10/17/02. Symptoms of abdominal pain started 10/21/02, vaginal bleeding started 10/21/02. On 10/23/02 was evaluated at medical clinic and then medical hospital. Dx and Rx for miscarriage.
3 months later my right Keratoconic eye unchanged in 30 years began to tear up and became lazy leading to double vision
MMRV was given to a 15 year old patient. Family to be notified and doses repeated if needed.
Pt had experienced a more recent similar rash previously after  receiving a vaccine in Aug 2021. Rash post- Pfizer vaccine #1 appeared <24hrs after vaccination. Pt had not pictures of first episode and was not seen for it. It resolved within 3 days. Reports only on eyelids and arms. Denies trunk involvement. Current rash appear approx 7 days ago and has worsened over the last 3 days. Initially over eyelids, but has since resolved. During her presentation today, she pw a slightly erythematous non-pruritic blanching morbiliform rash over her L>R AC and forearm with a clear border over medial aspect (not cw dermatomal distribution) with linear flat erythematous lesions c/w capillary damage (pt denies excoriation), R AC, R medial thigh with a clear demarcation on the posterior-medial surface (not cw dermatomal distribution), L medial thigh more diffuse and less concentrated without clear demarcation, and the most mild rash over her L antero-lateral abdomen without a clear demarcation (appeared last). No mucosal membrane involvement.
Information has been received from a physician concerning a 13 week old (reported as 3 month) female patient with a history of vomiting, diarrhoea, dehydration and hospitalization (the patient was hospitalized from 11-MAY-2012 to 14-MAY-2012 due to vomiting, diarrhoea, dehydration) with a negative results of medical test including stool cultures, "rotavirus", fecal blood cell, urine, blood, cerebral spinal fluid and respiratory cultures (the patient was administered unspecified antibiotics and was rehydrated) who on 15-MAY-2012 was vaccinated with a 2.0 ml first dose of ROTATEQ, (Lot # not reported). There was no concomitant medication. On 18-MAY-2012 the patient was found unresponsive at home after a nap. The patient was admitted to the hospital. Her rectal temperature was 100.01 and blood tests reflected dehydration. The patient was given IV fluids and supportive measures. The patient was pronounced dead on 18-MAY-2012. The physician reported, at autopsy, negative stool culture and positive rotavirus antigen ID. The caused of death has not yet been determined. Additional information has been requested. All adverse events were determined as significant disability, life threatening and other important medical events.
10 pm 6 hrs post vaccination achy joints knee joints very painful unable to sleep restless. After 8 hrs of sleeping woke up sat around 10 with very severe headache, unable to lift head or get out of bed due to pain . The absolute worst headache pain I have ever experienced almost went to we/urgent care because I was nervous and concered about the severity.  Constant pain and severe pressure at base of skull and in frontal lobe region/ forehead. Pain 10/10. Around 9 pm slight nausea and headache pain intermittent 7-8/10 tired lethargic after sitting up watching tv for 35 min.  Also kept having phantom burning smell  for a few hrs. Went back to bed Sunday unable to get out of bed due to severe headaches 8- 10/10 headache changed to more intermittent  sharp shooting pains with severe pressure that got worse with movement or when bending over. Headaches 9/10 pain and intermittent phantom burning smells and vinegar smell. Between 5-9 pm during intermittent sleep . Tired, joint pain mild  and very mild aches. Interrupted sleep with periods of no head pain with sharp quick very painful headaches triggered by restless moving or turning On Side. Headache subsided Monday around 7-10 then came back as mild constant headache.  Severe arm pain for 3 days that improved with magnesium supplements
Onset of itching left arm at site of injection w/ feet swelling and itching and progressed to hands, wrist and palm of hand/fingers and head and rt arm - not on truck accompanied w/ headache and tiredness.
This spontaneous report as received from a physician via a company representative refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date in May 2016, the patient was vaccinated with the first dose of ZOSTAVAX injection (exact dose, route of administration, anatomical location, lot #, expiration date were not provided). On 19-OCT-2016, the patient was inadvertently vaccinated with the second dose of ZOSTAVAX injection (exact dose, route of administration, anatomical location, lot #, expiration date were not provided). There were no adverse effects reported. Additional information is not expected because there was no consent to contact physician.
Patient called today and said she was administered a flu vaccine on Wednesday, Sept 28th at a flu clinic our store was part of. She called today and said that her arm was swollen at the injection site and was red, slightly warm to touch. Also there was a rash around the area the size of a softball No breathing issues. Patient saw a nurse and school and the nurse suggested she contact us. Told her to put ice on it and take benadryl. If still an issue on Monday or if it got worse- see a doctor.
Info has been received from a mfr. of Pediarix concerning an approximately 8 week old male with a history of breast feeding and who had no pre-existing medical conditions, who in June 2005, was vaccinated with a dose of MMRII. Concomitant vaccines administered on the same day included a 1st dose of Pediarix, a dose of Hib conj vaccine (manufacturer unknown) and a dose of Prevnar. It was noted that the pt received these vaccinations in both hips. Concomitant medications were not reported. In June 2005, the pt spiked a high fever of 103 F, was very sleepy and would not nurse. It was reported that the pt slept most of the following day. The pt was treated with Tylenol. Subsequently, the events resolved on an unspecified date in June 2005. It was noted that a physician or other health care professional has not verified this report. This was originally reported by the pt's mother. Additional info has been requested.
Over next hour, vomiting and sneezing.  Child vomited immediately then developed increased sneezing and facial swelling but lasted for several hours. Signs stated within an hour after the vaccines were given and lasted for several hours afterwards.
Pt described a half baseball size lump in the arm, also began running fever and chills, nausea, fainted, vomited.
Patient was given a fourth dose of HPV gardisil inadvertently because documentation in patient's chart was done poorly. Patient has not had any adverse reaction to date but the CDC asked us to fill out an adverse event about the incident.
About a week after my second dose I began feeling a congestion feeling that set into the middle of my chest in my bronchioles as if I was getting sick but had no other symptoms. It felt as if My lung capacity was restricted.  I cough during  heavy exertion and have ever since. It has been solid for over a year now.
Initial report was received 19 August 2011 which consisted of a cluster of two patients who experienced adverse events after receiving TYPHIM Vi, lot number E0549. This case represents one of the two patients. The other patient has been captured in case number 2011-07269. A 40-year-old male patient who had no concurrent illness and no past medical history had received an intramuscular right deltoid injection of TYPHIM V, lot number E0549 and an intradermal left forearm injection of TUBERSOL 5 TV, lot number C3761AA on 18 August 2011 and later that evening, he complained of a headache, dizziness and fatigue. The patient had not received any other vaccines within four weeks of TYPHIM Vi and TUBERSOL 5 TV. Outcome was not recovered. Documents held by sender: None.
Patient received 4 month vaccines slightly early with provider permission. Patient presented to clinic for 4 month well child examine. Patient received additional dose of 4 month vaccines. To writer's knowledge, patient is not having any adverse reaction or symptoms. Writer provided patient's mother with information regarding signs and symptoms of reaction that would require emergent medical assistance. Clinic management and provider were notified and safety report was filed through Medicine patient safety report system.
Ended up passing away about seven days after she received the second shot of the vaccine; Extreme headache; This is a spontaneous report from a non-contactable consumer. A female patient (reporter's mother) of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), for covid-19 immunisation. Patient actually took both of the vaccines and she experienced extreme headache after she received her second vaccine and she ended up passing away, she ended up passing away about seven days after she received the second shot of the vaccine. The outcome of headache was unknown, while other event was fatal. The patient died on an unspecified date. It was not reported if an autopsy was performed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Ended up passing away about seven days after she received the second shot of the vaccine
On 05/26/2001 the patient's left arm became swollen 3 times its normal size. The patient had a "whelpy" rash all over his body and was holding his throat. The patient was seen at the ER and was treated with Benadryl and Atarax.
1 hr p/vax pt had sx vomiting, fever & persistent crying;fever reached 104 ax;sx reported to MD;pt given medication for fever q 4 hr since vax but has vomited each feeding;referred to MD;
Patient was administered the COVID-19 vaccine during his inpatient  stay in the medical facility Early the next morning he complained of soreness and  an itchy rash on his arm, and later that afternoon he developed facial swelling that  the observing physician diagnosed as edema of the parotid gland. The patient  received 50 mg of diphenhydramine intramuscularly and fully recovered.
Pt reported rash developing on arm and other areas of back, felt feverish. Took BENARDRYL and symptoms have started to subside.
Headache, Myalgia, fatigue, chills Narrative:  Employee mild headache02/04/21, moderate myalgia 02/04/2021, moderate fatigue 02/05/21, chills 02/04/21 and 02/05/21. Resulted in unable to work 02/04/21 and 02/05/21. Did not seek medical attention for symptoms.
could not breath; had a "warm liquid running through her body" feeling/same sensation stated again today, 04Jan; dryness in the throat; This is a spontaneous report from a contactable consumer. A 42-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on 31Dec2020at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated she received the Pfizer covid vaccine on 31Dec2020 and she could not breath and had a "warm liquid running through her body" feeling that went away after some time. She said she has the same sensation stated again today, 04Jan2021 and this time it's not going away. She said it's been 10-15 minutes with this and also have dryness in the throat. She wanted to know if this was  normal. The patient said she was going to the emergency room.  Information on the lot/batch number has been requested.
Difficulty breathing; Muscle spasms; Decided not to get the second dose of Moderna vaccine due to her reaction; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), MUSCLE SPASMS (Muscle spasms) and INTENTIONAL PRODUCT USE ISSUE (Decided not to get the second dose of Moderna vaccine due to her reaction) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Difficulty breathing), MUSCLE SPASMS (Muscle spasms) and INTENTIONAL PRODUCT USE ISSUE (Decided not to get the second dose of Moderna vaccine due to her reaction). At the time of the report, DYSPNOEA (Difficulty breathing), MUSCLE SPASMS (Muscle spasms) and INTENTIONAL PRODUCT USE ISSUE (Decided not to get the second dose of Moderna vaccine due to her reaction) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow-up received on 10-May-2021, updated the outcome of the events (difficulty breathing and muscle spasms) and patient stated that she want to withdrawn her 2nd dose due to her reaction coded as event intentional deviation of dosage regimen.
Loss of appetite; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (Loss of appetite). At the time of the report, DECREASED APPETITE (Loss of appetite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment information was reported.
Dizziness, Headache, NauseaVomiting, tingling in hands bilateral, SOB Narrative: